Fighting and Stinging Responses are Affected by a Dopamine Receptor Blocker Flupenthixol in Honey Bee Virgin Queens
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Insect Behavior"
DOI: 10.1007/s10905-017-9650-0
Abstract: Fighting and aggression are important tasks for self-preservation in animals. In honey bees, virgin queens fight against each other for survival in a monogynous colony. Because the virgin queens have higher levels of dopamine (DA)… read more here.
Keywords: fighting stinging; bee virgin; receptor blocker; virgin ... See more keywords
Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection
Sign Up to like & getrecommendations! Published in 2018 at "Life Sciences"
DOI: 10.1016/j.lfs.2018.04.033
Abstract: Aims: Neuroinflammation has a critical role in brain diseases. Angiotensin II (Ang II) is an important player in inflammation via stimulating of Ang II type 1 receptor (AT1R). In this study, the effects of losartan,… read more here.
Keywords: receptor blocker; consequences lipopolysaccharide; behavioral consequences; injection ... See more keywords
Combined effects of angiotensin receptor blocker use and physical training in hypertensive men
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Hypertension"
DOI: 10.1080/10641963.2022.2055763
Abstract: ABSTRACT Purpose Pharmacological (angiotensin II receptor type 1 receptor blocker use) and non-pharmacological treatment (physical aerobic exercise) are important strategies to reduces blood pressure and control arterial hypertension; however, only few clinical studies have evaluated… read more here.
Keywords: training; blocker use; receptor blocker; physical aerobic ... See more keywords
ANTI-INFLAMMATORY EFFECTS AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPAR GAMMA)-ACTIVATING PROPERTIES OF THE ANGIOTENSIN TYPE 1 RECEPTOR BLOCKER TELMISARTAN IN PATIENTS
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000838824.44837.1f
Abstract: Objective: Metabolic syndrome (MetS) is a collection of disorders including diabetes, hypertension, obesity, and dyslipidemia that increase the risk of cardiovascular diseases and mortality. Several studies have discovered that, in addition to its angiotensin receptor… read more here.
Keywords: peroxisome proliferator; proliferator activated; gamma; receptor blocker ... See more keywords
Angiotensin‐receptor blocker losartan alleviates atrial fibrillation in rats by downregulating frizzled 8 and inhibiting the activation of WNT‐5A pathway
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Pharmacology and Physiology"
DOI: 10.1111/1440-1681.13715
Abstract: Atrial fibrillation (AF) is a common arrhythmia. Angiotensin‐receptor blocker (ARB) is related to AF treatment. This study explored the mechanism of ARB in AF. AF rat models were established by Ach‐CaCl2 mixed solution injection. Rats… read more here.
Keywords: fibrosis; arb; receptor blocker; wnt pathway ... See more keywords
The effectiveness and safety of topical β-receptor blocker in treating superficial infantile hemangiomas: a meta-analysis including 20 studies.
Sign Up to like & getrecommendations! Published in 2019 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.14196
Abstract: OBJECTIVE To evaluate the effectiveness and safety of topical β-receptor blocker in treating superficial infantile hemangiomas (SIH) and compare the effectiveness and safety of topical β-receptor blocker against other therapies. METHODS A search of the… read more here.
Keywords: receptor blocker; effectiveness safety; propranolol; topical receptor ... See more keywords
Combined treatment with dipeptidyl peptidase‐4 inhibitor (sitagliptin) and angiotensin‐II type 1 receptor blocker (losartan) suppresses progression in a non‐diabetic rat model of steatohepatitis
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology Research"
DOI: 10.1111/hepr.12860
Abstract: Dipeptidyl peptidase‐4 (DPP4) inhibitors (DPP4‐I) are oral glucose‐lowering drugs for type 2 diabetes mellitus. Previously, we reported that DPP4‐I (sitagliptin) exerted suppressive effects on experimental liver fibrosis in rats. Blockade of the renin–angiotensin system by… read more here.
Keywords: type receptor; receptor blocker; dipeptidyl peptidase; type ... See more keywords
Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease
Sign Up to like & getrecommendations! Published in 2018 at "Hypertension"
DOI: 10.1161/hypertensionaha.118.11775
Abstract: The angiotensin receptor blocker losartan mitigated cerebrovascular and cognitive deficits in mouse models of Alzheimer disease, in line with some clinical evidence of reduced onset and progression to Alzheimer disease. We investigated whether these benefits… read more here.
Keywords: receptor blocker; angiotensin receptor; alzheimer disease;
Lesson Learnt from Recall of Valsartan and Other Angiotensin II Receptor Blocker Drugs Containing NDMA and NDEA Impurities
Sign Up to like & getrecommendations! Published in 2019 at "AAPS PharmSciTech"
DOI: 10.1208/s12249-019-1376-1
Abstract: The presence of N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) impurities in angiotensin II receptor blocker (ARB) drugs containing tetrazole ring has triggered worldwide product recalls. The purpose of this article is to identify the potential gap… read more here.
Keywords: receptor blocker; angiotensin receptor; drugs containing; ndea impurities ... See more keywords
Pediatric heart failure therapy: why β1-receptor blocker, tissue ACE-I and mineralocorticoid-receptor-blocker?
Sign Up to like & getrecommendations! Published in 2019 at "Translational pediatrics"
DOI: 10.21037/tp.2019.04.08
Abstract: Pediatric heart failure (HF) treatment lagged behind the knowledge of pharmacological research and evidence-based clinical experience in adults. Considering the lack of prospective, double blind randomized studies in children, the review is focused on the… read more here.
Keywords: receptor; pediatric heart; heart failure; receptor blocker ... See more keywords
Podocyte-Related Mechanisms Underlying Survival Benefit of Long-Term Angiotensin Receptor Blocker
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23116018
Abstract: We previously found that short-term treatment (week 8 to 12 after injury) with high-dose angiotensin receptor blocker (ARB) induced the regression of existing glomerulosclerosis in 5/6 nephrectomy rats. We therefore assessed the effects of long-term… read more here.
Keywords: long term; arb; receptor blocker; term ... See more keywords